000 01488 a2200433 4500
005 20250513144548.0
264 0 _c19980714
008 199807s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI498
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHicklin, D J
245 0 0 _abeta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cJun 1998
300 _a2720-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAmino Acid Sequence
650 0 4 _aBase Sequence
650 0 4 _aCell Division
_xgenetics
650 0 4 _aFrameshift Mutation
650 0 4 _aGene Expression Regulation, Neoplastic
_ximmunology
650 0 4 _aHistocompatibility Antigens Class I
_xgenetics
650 0 4 _aHumans
650 0 4 _aMelanoma
_xgenetics
650 0 4 _aMolecular Sequence Data
650 0 4 _aPoint Mutation
650 0 4 _aRNA Splicing
650 0 4 _aTransfection
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Escape
_xgenetics
650 0 4 _abeta 2-Microglobulin
_xgenetics
700 1 _aWang, Z
700 1 _aArienti, F
700 1 _aRivoltini, L
700 1 _aParmiani, G
700 1 _aFerrone, S
773 0 _tThe Journal of clinical investigation
_gvol. 101
_gno. 12
_gp. 2720-9
856 4 0 _uhttps://doi.org/10.1172/JCI498
_zAvailable from publisher's website
999 _c9603984
_d9603984